The Effect of Hormones Insulin and Glucagon on Ubiquitin Modifications Elucidated by Proteomics in Liver Cells

Overview

Journal Life Sci

Publisher Elsevier

Specialties Biochemistry
Biology
Physiology

Date 2023 Jul 13

PMID 37442415

Authors

Hari Priya Vemana

Vikas V Dukhande

Affiliations

Soon will be listed here.

Abstract

Aims: Insulin action is intertwined with changing levels of glucose and counter-regulatory hormone glucagon. While insulin lowers blood sugar level, glucagon raises it by promoting the breakdown of the stored glycogen in liver and releases glucose into the bloodstream. The hormones insulin and glucagon are key in the pathogenesis of type 2 diabetes (T2D). Insulin resistance is a primary predisposing factor for diabetes. Phosphorylation of insulin signaling molecules is altered in the insulin-resistant state. However, ubiquitin (Ub) modifications in insulin-resistant state are relatively understudied. To dissect the underlying mechanisms, we performed a proteomics study on hepatoma cells to study the regulation of ubiquitination by insulin and glucagon.

Materials And Methods: We performed western blotting, immunoprecipitations, and affinity pull down using tandem Ub binding entities (TUBE) reagents on hepatoma cells treated with insulin or glucagon. Next, we performed MS/MS analysis on Ub-linkage specific affinity pull down samples. Gene ontology analysis and protein-protein interaction network analysis was performed using DAVID GO and STRING db, respectively.

Key Findings: The ubiquitination pattern of total Ub, K48-linked Ub, and K63-linked Ub was altered with the treatment of hormones insulin and glucagon. Ubiquitination in immunoprecipitated samples showed enrichment with total Ub and K48-linked Ub but not with K63-linked Ub. Ubiquitination by treatment with hormones mainly enriched key signaling pathways MAPK, Akt, oxidative stress etc. SIGNIFICANCE: Our study identified key altered proteins and signal transduction pathways which aids in understanding the mechanisms of hormonal action on ubiquitination and identify new therapeutic targets for T2D.

References

Boucher J, Kleinridders A, Kahn C . Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014; 6(1). PMC: 3941218. DOI: 10.1101/cshperspect.a009191. View

Hsieh Y, Yeh M, Lin Y, Weng S, Hsu C, Huang C . Is the level of serum lactate dehydrogenase a potential biomarker for glucose monitoring with type 2 diabetes mellitus?. Front Endocrinol (Lausanne). 2023; 13:1099805. PMC: 9801409. DOI: 10.3389/fendo.2022.1099805. View

Haeusler R, McGraw T, Accili D . Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol. 2017; 19(1):31-44. PMC: 5894887. DOI: 10.1038/nrm.2017.89. View

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

Krishna R, Wold F . Post-translational modification of proteins. Adv Enzymol Relat Areas Mol Biol. 1993; 67:265-98. DOI: 10.1002/9780470123133.ch3. View

Lu Y, Li Y, Li G, Lu H . Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis. Mol Med Rep. 2020; 22(3):1868-1882. PMC: 7411335. DOI: 10.3892/mmr.2020.11281. View

Maqbool M, Hoda N . GSK3 Inhibitors in the Therapeutic Development of Diabetes, Cancer and Neurodegeneration: Past, Present and Future. Curr Pharm Des. 2017; 23(29):4332-4350. DOI: 10.2174/1381612823666170714141450. View

Cargnello M, Roux P . Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011; 75(1):50-83. PMC: 3063353. DOI: 10.1128/MMBR.00031-10. View

Mihaylova M, Vasquez D, Ravnskjaer K, Denechaud P, Yu R, Alvarez J . Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell. 2011; 145(4):607-21. PMC: 3117637. DOI: 10.1016/j.cell.2011.03.043. View

10.

Fulzele A, Bennett E . Ubiquitin diGLY Proteomics as an Approach to Identify and Quantify the Ubiquitin-Modified Proteome. Methods Mol Biol. 2018; 1844:363-384. PMC: 6791129. DOI: 10.1007/978-1-4939-8706-1_23. View

11.

Cui M, Cheng C, Zhang L . High-throughput proteomics: a methodological mini-review. Lab Invest. 2022; 102(11):1170-1181. PMC: 9362039. DOI: 10.1038/s41374-022-00830-7. View

12.

Tracz M, Bialek W . Beyond K48 and K63: non-canonical protein ubiquitination. Cell Mol Biol Lett. 2021; 26(1):1. PMC: 7786512. DOI: 10.1186/s11658-020-00245-6. View

13.

Lee Y, Wang M, Du X, Charron M, Unger R . Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes. 2011; 60(2):391-7. PMC: 3028337. DOI: 10.2337/db10-0426. View

14.

Zhang S, Guo F, Yu M, Yang X, Yao Z, Li Q . Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity. J Hepatol. 2020; 73(6):1482-1495. DOI: 10.1016/j.jhep.2020.07.034. View

15.

Yang W, Wang J, Chan C, Lee S, Campos A, Lamothe B . The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science. 2009; 325(5944):1134-8. PMC: 3008763. DOI: 10.1126/science.1175065. View

16.

Komander D, Rape M . The ubiquitin code. Annu Rev Biochem. 2012; 81:203-29. DOI: 10.1146/annurev-biochem-060310-170328. View

17.

Wang Y, Zhou H, Palyha O, Mu J . Restoration of insulin receptor improves diabetic phenotype in T2DM mice. JCI Insight. 2019; 4(15). PMC: 6693840. DOI: 10.1172/jci.insight.124945. View

18.

Kulathu Y, Komander D . Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol. 2012; 13(8):508-23. DOI: 10.1038/nrm3394. View

19.

Pino L, Rose J, OBroin A, Shah S, Schilling B . Emerging mass spectrometry-based proteomics methodologies for novel biomedical applications. Biochem Soc Trans. 2020; 48(5):1953-1966. PMC: 7609030. DOI: 10.1042/BST20191091. View

20.

Yang L, Zhang Z, Wang D, Jiang Y, Liu Y . Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications. Curr Drug Targets. 2022; 23(7):692-710. DOI: 10.2174/1389450123666220111115528. View